The Social Construction of Aging Among a Clinic-Based Population and Their Healthcare Workers in Zambia.


Journal

International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551

Informations de publication

Date de publication:
2024
Historique:
received: 09 09 2023
accepted: 01 04 2024
medline: 7 5 2024
pubmed: 7 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

We sought to understand the social construction of aging in a clinic-based population, with and without HIV, to address gaps in care for older individuals living with HIV in Zambia. Our exploratory qualitative study included 36 in-depth interviews with clinic clients and four focus group discussions with 36 professional and lay healthcare workers providing services to the clients. We identified themes based on social construction theory. At the individual level, aging was multidimensional, perceived both as an achievement in the HIV era and as a period of cognitive, physical, and economic decline. In social interactions, older individuals were often stereotyped and treated as helpless, poor, and "witches." Those living with HIV faced the additional stigma of being labeled as promiscuous. Some of the participants living without HIV refused to take daily medication for non-communicable diseases to avoid being mistaken for taking antiretroviral therapy for HIV. Older individuals wanted quality healthcare and family support to address the intersectional stigma of aging, poverty, and chronic illness. Multifaceted interventions are required to combat age-related prejudice, intersectional stigma, and discriminatory practices, particularly for people living with HIV.

Identifiants

pubmed: 38711786
doi: 10.3389/ijph.2024.1606607
pii: 1606607
pmc: PMC11070831
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1606607

Informations de copyright

Copyright © 2024 Sharma, Mwamba, St Clair-Sullivan, Chihota, Pry, Bolton-Moore, Vinikoor, Muula, Daultrey, Gittelsohn, Mulenga, Siyumbwa, Wandeler and Vera.

Déclaration de conflit d'intérêts

The authors declare that they do not have any conflicts of interest.

Auteurs

Anjali Sharma (A)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Chanda Mwamba (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Natalie St Clair-Sullivan (N)

Brighton and Sussex Medical School, Brighton, United Kingdom.

Belinda V Chihota (BV)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Department of Preclinical Medicine, Faculty of Medicine, Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Jake M Pry (JM)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
School of Medicine, University of California, Davis, Sacramento, CA, United States.

Carolyn Bolton-Moore (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Michael J Vinikoor (MJ)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Guy K Muula (GK)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Harriet Daultrey (H)

Brighton and Sussex Medical School, Brighton, United Kingdom.

Joel Gittelsohn (J)

Center for Human Nutrition, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.

Lloyd B Mulenga (LB)

Ministry of Health, Lusaka Zambia, Lusaka, Zambia.

Namasiku Siyumbwa (N)

Ministry of Health, Lusaka Zambia, Lusaka, Zambia.

Gilles Wandeler (G)

Brighton and Sussex Medical School, Brighton, United Kingdom.
Medical Faculty, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Jaime H Vera (JH)

Brighton and Sussex Medical School, Brighton, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH